ABG Analytics logo
Get updates

Eli Lilly & Company (NYSE: LLY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 07/02/2020
Closing price: 163.87
Support price level: $160.51
Resistance price level: N/A
Relative strength index (14-day RSI) 73.6
Beta 0.50
  • LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • With a 43.2 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.

  • The price of this low-beta stock is expected to increase by 0.50% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$106.79 $164.18 99.6%
200 day 50 day 20 day 10 day
$134.76 $155.56 $156.45 $161.65
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.6% 25.2% 38.5% 30.0%
There is an estimated 5% probability that the stock price of Eli Lilly & Company will fall by more than:
  • 10.5% in the next week.

  • 17.0% in the next month.

  • 63.4% in the next year.